APO Research
Talk to an analyst

APO RESEARCH · REPORT

Arbidol Hydrochloride (COVID-19)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Arbidol Hydrochloride (COVID-19) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026182 pages

Choose your research edition.

Industry ResearchArbidol Hydrochloride (COVID-19) Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Arbidol Hydrochloride (COVID-19) Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Arbidol Hydrochloride (COVID-19) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Arbidol Hydrochloride (COVID-19) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Arbidol Hydrochloride (COVID-19) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Arbidol Hydrochloride (COVID-19) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Arbidol Hydrochloride (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Arbidol Hydrochloride (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Arbidol Hydrochloride (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Arbidol Hydrochloride (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Arbidol Hydrochloride (COVID-19) include Simcere Pharmaceutical, CSPC Ouyi Pharmaceutical, Jiangsu Wuzhong Pharmaceutical, Jiangsu Lianshui Pharmaceutical and JSC Pharmstandard, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Arbidol Hydrochloride (COVID-19) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Arbidol Hydrochloride (COVID-19) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Arbidol Hydrochloride (COVID-19) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Arbidol Hydrochloride (COVID-19) market size, projected growth trends, production technologies, key applications, and end-use industries.

Arbidol Hydrochloride (COVID-19) Segment by Company

Simcere Pharmaceutical

CSPC Ouyi Pharmaceutical

Jiangsu Wuzhong Pharmaceutical

Jiangsu Lianshui Pharmaceutical

JSC Pharmstandard

Arbidol Hydrochloride (COVID-19) Segment by Type

Arbidol Hydrochloride Capsules

Arbidol Hydrochloride Granules

Arbidol Hydrochloride Tablets

Arbidol Hydrochloride (COVID-19) Segment by Application

Anti Influenza Virus

COVID-19

Arbidol Hydrochloride (COVID-19) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arbidol Hydrochloride (COVID-19) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Arbidol Hydrochloride (COVID-19) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arbidol Hydrochloride (COVID-19).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Arbidol Hydrochloride (COVID-19) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Arbidol Hydrochloride (COVID-19) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Arbidol Hydrochloride (COVID-19) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Arbidol Hydrochloride (COVID-19) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Arbidol Hydrochloride (COVID-19) Industry Trends Table 2. Arbidol Hydrochloride (COVID-19) Industry Drivers Table 3. Arbidol Hydrochloride (COVID-19) Industry Opportunities and Challenges Table 4. Arbidol Hydrochloride (COVID-19) Industry Restraints Table 5. Global Arbidol Hydrochloride (COVID-19) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Arbidol Hydrochloride (COVID-19) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Manufacturers Table 9. Global Arbidol Hydrochloride (COVID-19) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Arbidol Hydrochloride (COVID-19) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Arbidol Hydrochloride (COVID-19) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Arbidol Hydrochloride (COVID-19) Manufacturers, Product Type & Application Table 13. Global Arbidol Hydrochloride (COVID-19) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Arbidol Hydrochloride (COVID-19) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Arbidol Hydrochloride Capsules Table 17. Major Manufacturers of Arbidol Hydrochloride Granules Table 18. Major Manufacturers of Arbidol Hydrochloride Tablets Table 19. Global Arbidol Hydrochloride (COVID-19) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2026) & (K Units) Table 21. Global Arbidol Hydrochloride (COVID-19) Sales by Type (2027-2032) & (K Units) Table 22. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Type (2021-2026) Table 23. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Type (2027-2032) Table 24. Global Arbidol Hydrochloride (COVID-19) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Arbidol Hydrochloride (COVID-19) Revenue by Type (2021-2026) & (K Units) Table 26. Global Arbidol Hydrochloride (COVID-19) Revenue by Type (2027-2032) & (K Units) Table 27. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Type (2021-2026) Table 28. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Anti Influenza Virus Table 30. Major Manufacturers of COVID-19 Table 31. Global Arbidol Hydrochloride (COVID-19) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2026) & (K Units) Table 33. Global Arbidol Hydrochloride (COVID-19) Sales by Application (2027-2032) & (K Units) Table 34. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Application (2021-2026) Table 35. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Application (2027-2032) Table 36. Global Arbidol Hydrochloride (COVID-19) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Arbidol Hydrochloride (COVID-19) Revenue by Application (2021-2026) & (K Units) Table 38. Global Arbidol Hydrochloride (COVID-19) Revenue by Application (2027-2032) & (K Units) Table 39. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Application (2021-2026) Table 40. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Application (2027-2032) Table 41. Global Arbidol Hydrochloride (COVID-19) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Arbidol Hydrochloride (COVID-19) Sales by Region (2021-2026) & (K Units) Table 43. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Region (2021-2026) Table 44. Global Arbidol Hydrochloride (COVID-19) Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Arbidol Hydrochloride (COVID-19) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Arbidol Hydrochloride (COVID-19) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026) & (K Units) Table 48. North America Arbidol Hydrochloride (COVID-19) Sales by Country (2027-2032) & (K Units) Table 49. Europe Arbidol Hydrochloride (COVID-19) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026) & (K Units) Table 51. Europe Arbidol Hydrochloride (COVID-19) Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Arbidol Hydrochloride (COVID-19) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Arbidol Hydrochloride (COVID-19) Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales by Country (2027-2032) & (K Units) Table 58. Global Arbidol Hydrochloride (COVID-19) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Arbidol Hydrochloride (COVID-19) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Arbidol Hydrochloride (COVID-19) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Region (2021-2026) Table 62. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Region (2027-2032) Table 63. Simcere Pharmaceutical Company Information Table 64. Simcere Pharmaceutical Business Overview Table 65. Simcere Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Simcere Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio Table 67. Simcere Pharmaceutical Recent Development Table 68. CSPC Ouyi Pharmaceutical Company Information Table 69. CSPC Ouyi Pharmaceutical Business Overview Table 70. CSPC Ouyi Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. CSPC Ouyi Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio Table 72. CSPC Ouyi Pharmaceutical Recent Development Table 73. Jiangsu Wuzhong Pharmaceutical Company Information Table 74. Jiangsu Wuzhong Pharmaceutical Business Overview Table 75. Jiangsu Wuzhong Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Jiangsu Wuzhong Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio Table 77. Jiangsu Wuzhong Pharmaceutical Recent Development Table 78. Jiangsu Lianshui Pharmaceutical Company Information Table 79. Jiangsu Lianshui Pharmaceutical Business Overview Table 80. Jiangsu Lianshui Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Jiangsu Lianshui Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio Table 82. Jiangsu Lianshui Pharmaceutical Recent Development Table 83. JSC Pharmstandard Company Information Table 84. JSC Pharmstandard Business Overview Table 85. JSC Pharmstandard Arbidol Hydrochloride (COVID-19) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. JSC Pharmstandard Arbidol Hydrochloride (COVID-19) Product Portfolio Table 87. JSC Pharmstandard Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Arbidol Hydrochloride (COVID-19) Distributors List Table 91. Arbidol Hydrochloride (COVID-19) Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Arbidol Hydrochloride (COVID-19) Product Image Figure 2. Global Arbidol Hydrochloride (COVID-19) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Arbidol Hydrochloride (COVID-19) Market Size (2021-2032) & (US$ Million) Figure 4. Global Arbidol Hydrochloride (COVID-19) Sales (2021-2032) & (K Units) Figure 5. Global Arbidol Hydrochloride (COVID-19) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Arbidol Hydrochloride (COVID-19) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Arbidol Hydrochloride Capsules Image Figure 9. Arbidol Hydrochloride Granules Image Figure 10. Arbidol Hydrochloride Tablets Image Figure 11. Global Arbidol Hydrochloride (COVID-19) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Arbidol Hydrochloride (COVID-19) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Type (2021-2032) Figure 14. Global Arbidol Hydrochloride (COVID-19) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Type (2021-2032) Figure 17. Anti Influenza Virus Image Figure 18. COVID-19 Image Figure 19. Global Arbidol Hydrochloride (COVID-19) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Arbidol Hydrochloride (COVID-19) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Application (2021-2032) Figure 22. Global Arbidol Hydrochloride (COVID-19) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Application (2021-2032) Figure 25. North America Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Arbidol Hydrochloride (COVID-19) Sales Market Share by Country (2021-2032) Figure 27. U.S. Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Arbidol Hydrochloride (COVID-19) Sales Market Share by Country (2021-2032) Figure 32. Germany Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Arbidol Hydrochloride (COVID-19) Sales Market Share by Country (2021-2032) Figure 39. China Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Market Share by Country (2021-2032) Figure 47. Brazil Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Arbidol Hydrochloride (COVID-19) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Arbidol Hydrochloride (COVID-19) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Arbidol Hydrochloride (COVID-19) Revenue (2021-2032) & (US$ Million) Figure 58. North America Arbidol Hydrochloride (COVID-19) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Arbidol Hydrochloride (COVID-19) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Arbidol Hydrochloride (COVID-19) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Arbidol Hydrochloride (COVID-19) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Arbidol Hydrochloride (COVID-19) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Arbidol Hydrochloride (COVID-19) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Arbidol Hydrochloride (COVID-19) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Arbidol Hydrochloride (COVID-19) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Arbidol Hydrochloride (COVID-19) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Arbidol Hydrochloride Capsules
  • Arbidol Hydrochloride Granules
  • Arbidol Hydrochloride Tablets
Applications
  • Anti Influenza Virus
  • COVID-19
Companies covered
  • Simcere Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • Jiangsu Wuzhong Pharmaceutical
  • Jiangsu Lianshui Pharmaceutical
  • JSC Pharmstandard

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Arbidol Hydrochloride (COVID-19) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Arbidol Hydrochloride (COVID-19) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Arbidol Hydrochloride (COVID-19) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Arbidol Hydrochloride (COVID-19) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Arbidol Hydrochloride (COVID-19) Market Dynamics
  1. 2.1 Arbidol Hydrochloride (COVID-19) Industry Trends
  2. 2.2 Arbidol Hydrochloride (COVID-19) Industry Drivers
  3. 2.3 Arbidol Hydrochloride (COVID-19) Industry Opportunities and Challenges
  4. 2.4 Arbidol Hydrochloride (COVID-19) Industry Restraints
3 Arbidol Hydrochloride (COVID-19) Market by Manufacturers
  1. 3.1 Global Arbidol Hydrochloride (COVID-19) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Arbidol Hydrochloride (COVID-19) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Arbidol Hydrochloride (COVID-19) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Arbidol Hydrochloride (COVID-19) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Arbidol Hydrochloride (COVID-19) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Arbidol Hydrochloride (COVID-19) Manufacturers, Product Type & Application
  7. 3.7 Global Arbidol Hydrochloride (COVID-19) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Arbidol Hydrochloride (COVID-19) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Arbidol Hydrochloride (COVID-19) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Arbidol Hydrochloride (COVID-19) Tier 1, Tier 2, and Tier 3
4 Arbidol Hydrochloride (COVID-19) Market by Type
  1. 4.1 Arbidol Hydrochloride (COVID-19) Type Introduction
  2. 4.1.1 Arbidol Hydrochloride Capsules
  3. 4.1.2 Arbidol Hydrochloride Granules
  4. 4.1.3 Arbidol Hydrochloride Tablets
  5. 4.2 Global Arbidol Hydrochloride (COVID-19) Sales by Type
  6. 4.2.1 Global Arbidol Hydrochloride (COVID-19) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Arbidol Hydrochloride (COVID-19) Sales by Type (2021-2032)
  8. 4.2.3 Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Arbidol Hydrochloride (COVID-19) Revenue by Type
  10. 4.3.1 Global Arbidol Hydrochloride (COVID-19) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Arbidol Hydrochloride (COVID-19) Revenue by Type (2021-2032)
  12. 4.3.3 Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Type (2021-2032)
5 Arbidol Hydrochloride (COVID-19) Market by Application
  1. 5.1 Arbidol Hydrochloride (COVID-19) Application Introduction
  2. 5.1.1 Anti Influenza Virus
  3. 5.1.2 COVID-19
  4. 5.2 Global Arbidol Hydrochloride (COVID-19) Sales by Application
  5. 5.2.1 Global Arbidol Hydrochloride (COVID-19) Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Arbidol Hydrochloride (COVID-19) Sales by Application (2021-2032)
  7. 5.2.3 Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Application (2021-2032)
  8. 5.3 Global Arbidol Hydrochloride (COVID-19) Revenue by Application
  9. 5.3.1 Global Arbidol Hydrochloride (COVID-19) Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Arbidol Hydrochloride (COVID-19) Revenue by Application (2021-2032)
  11. 5.3.3 Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Application (2021-2032)
6 Global Arbidol Hydrochloride (COVID-19) Sales by Region
  1. 6.1 Global Arbidol Hydrochloride (COVID-19) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Arbidol Hydrochloride (COVID-19) Sales by Region (2021-2032)
  3. 6.2.1 Global Arbidol Hydrochloride (COVID-19) Sales by Region (2021-2026)
  4. 6.2.2 Global Arbidol Hydrochloride (COVID-19) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Arbidol Hydrochloride (COVID-19) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Arbidol Hydrochloride (COVID-19) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Arbidol Hydrochloride (COVID-19) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Arbidol Hydrochloride (COVID-19) Revenue by Region
  1. 7.1 Global Arbidol Hydrochloride (COVID-19) Revenue by Region
  2. 7.1.1 Global Arbidol Hydrochloride (COVID-19) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Arbidol Hydrochloride (COVID-19) Revenue by Region (2021-2026)
  4. 7.1.3 Global Arbidol Hydrochloride (COVID-19) Revenue by Region (2027-2032)
  5. 7.1.4 Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Arbidol Hydrochloride (COVID-19) Revenue (2021-2032)
  8. 7.2.2 North America Arbidol Hydrochloride (COVID-19) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Arbidol Hydrochloride (COVID-19) Revenue (2021-2032)
  11. 7.3.2 Europe Arbidol Hydrochloride (COVID-19) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Arbidol Hydrochloride (COVID-19) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Arbidol Hydrochloride (COVID-19) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Arbidol Hydrochloride (COVID-19) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Arbidol Hydrochloride (COVID-19) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Simcere Pharmaceutical
  2. 8.1.1 Simcere Pharmaceutical Company Information
  3. 8.1.2 Simcere Pharmaceutical Business Overview
  4. 8.1.3 Simcere Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Simcere Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio
  6. 8.1.5 Simcere Pharmaceutical Recent Developments
  7. 8.2 CSPC Ouyi Pharmaceutical
  8. 8.2.1 CSPC Ouyi Pharmaceutical Company Information
  9. 8.2.2 CSPC Ouyi Pharmaceutical Business Overview
  10. 8.2.3 CSPC Ouyi Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CSPC Ouyi Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio
  12. 8.2.5 CSPC Ouyi Pharmaceutical Recent Developments
  13. 8.3 Jiangsu Wuzhong Pharmaceutical
  14. 8.3.1 Jiangsu Wuzhong Pharmaceutical Company Information
  15. 8.3.2 Jiangsu Wuzhong Pharmaceutical Business Overview
  16. 8.3.3 Jiangsu Wuzhong Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Wuzhong Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio
  18. 8.3.5 Jiangsu Wuzhong Pharmaceutical Recent Developments
  19. 8.4 Jiangsu Lianshui Pharmaceutical
  20. 8.4.1 Jiangsu Lianshui Pharmaceutical Company Information
  21. 8.4.2 Jiangsu Lianshui Pharmaceutical Business Overview
  22. 8.4.3 Jiangsu Lianshui Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Lianshui Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio
  24. 8.4.5 Jiangsu Lianshui Pharmaceutical Recent Developments
  25. 8.5 JSC Pharmstandard
  26. 8.5.1 JSC Pharmstandard Company Information
  27. 8.5.2 JSC Pharmstandard Business Overview
  28. 8.5.3 JSC Pharmstandard Arbidol Hydrochloride (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 JSC Pharmstandard Arbidol Hydrochloride (COVID-19) Product Portfolio
  30. 8.5.5 JSC Pharmstandard Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Arbidol Hydrochloride (COVID-19) Value Chain Analysis
  2. 9.1.1 Arbidol Hydrochloride (COVID-19) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Arbidol Hydrochloride (COVID-19) Production Mode & Process
  6. 9.2 Arbidol Hydrochloride (COVID-19) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Arbidol Hydrochloride (COVID-19) Distributors
  9. 9.2.3 Arbidol Hydrochloride (COVID-19) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst